- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
- 10-K Annual report
- 10.50 Separation Letter Agreement and General Release
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Grant Thornton LLP
- 31.1 Certification of Principal Executive Officer Pursuant to Section 302
- 31.2 Certification of Principal Financial Officer Pursuant to Section 302
- 32.1 Certification of Principal Executive Officer Pursuant to Section 906
- 32.2 Certification of Principal Financial Officer Pursuant to Section 906
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 6, 2012, with respect to the consolidated financial statements and schedule included in the Annual Report of Cornerstone Therapeutics Inc. on Form 10-K for the year ended December 31, 2011. We hereby consent to the incorporation by reference of said report in the Registration Statements of Cornerstone Therapeutics Inc. on Forms S-8 (File No. 333-119409, effective September 30, 2004, File No. 333-125892, effective June 17, 2005, File No. 333-131037, effective January 13, 2006, File No. 333-133867, effective May 5, 2006, File No. 333-156293, effective December 19, 2008, File No. 333-161326, effective August 13, 2009 and File No. 333-168542, effective August 5, 2010) and S-3 (File No. 333-166770, effective May 18, 2011).
/s/ GRANT THORNTON LLP
Raleigh, North Carolina
March 6, 2012